FDA, EMA to Collaborate on Inspections for Generic Applications

Drug Industry Daily
A A
The FDA and EMA will expand their joint inspection activities to include facilities involved with bioequivalence studies for generic drug applications.

To View This Article:

Login

Subscribe To Drug Industry Daily